封面
市場調查報告書
商品編碼
1098620

布氏桿菌症疫苗的市場規模、佔有率、展望、機會 (2022年~2030年):各類型 (RB51疫苗、S19疫苗、B19疫苗、其他)、用途 (牛、羊、山羊、其他)、地區

Brucellosis Vaccines Market, by Type (RB51 Vaccine, S19 Vaccine, B19 Vaccine and Others ), by Application (Cattle, Sheep, Goat and Others ), and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

出版日期: | 出版商: Coherent Market Insights | 英文 149 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

布氏桿菌症的盛行率增加促進在預測期間內的全球布氏桿菌症疫苗市場成長。

本報告提供全球布氏桿菌症疫苗的市場調查,市場定義和概要,市場成長的各種影響因素分析,法律制度,市場規模的變化、預測,各種區分、各地區/主要國家的明細,競爭環境,主要企業簡介等彙整資訊。

目錄

第1章 調查目的、前提條件

第2章 市場概要

第3章 市場動態、法規、趨勢分析

  • 促進因素
  • 阻礙因素
  • 市場機會
  • 影響分析
  • 市場趨勢
  • 主要的展開
  • 產品銷售
  • 法規指南
  • 收購、聯盟、合作
  • 流行病學
  • PEST分析

第4章 全球布氏桿菌症疫苗市場:COVID-19影響

  • 經濟影響
  • 需求與供給的分析

第5章 全球布氏桿菌症疫苗市場:各類型

  • RB51疫苗
  • S19疫苗
  • B19疫苗
  • 其他(45/20疫苗,SR82疫苗等)

第6章 全球布氏桿菌症疫苗市場:各用途

  • 綿羊
  • 山羊
  • 其他(豬,馬等)

第7章 全球布氏桿菌症疫苗市場:各地區

  • 北美
  • 南美
  • 歐洲
  • 亞太地區
  • 中東
  • 非洲

第8章 競爭情形

  • 競爭概述
    • Merck &Co., Inc.
    • CZ Vaccines
    • Colorado Serum Company
    • Indian Immunologicals Ltd.
    • Hester Biosciences Limited
    • Veterinary Technologies Corporation
    • Jordan Bio-industries Center
    • Laboratorios Tornel
    • Fivet Animal Health
    • VETAL Animal Health Products Inc.

第9章 Section

簡介目錄
Product Code: CMI5038

Brucellosis is an infectious disease caused by bacteria. Animals that are most commonly infected include sheep, cattle, goats, pigs, and dogs, among others. These disease can also occur in humans when they are in contact with infected animals or animal products contaminated with bacteria.

Moreover, RB51 Vaccine, S19 Vaccine, B19 Vaccine and Others (45/20 vaccine, SR82 vaccine, etc.) are the type of vaccine used for the brucellosis in animals.

Furthermore, increasing launches of brucellosis vaccination programmes is expected to drive the market growth over the forecast period.

In August 2021, brucella vaccination program was launched at Thoubal, Manipur, India for the control and eradication of brucellosis in female calves of 4-8 months age group.

Market Dynamics

Increasing prevalence of brucellosis is expected to drive the global brucellosis vaccines market growth over the forecast period. For instance, according to an article published by the National Center for Biotechnology Information, a series of databases relevant to biotechnology and biomedicine, brucellosis is the world's most widespread zoonotic disease, a type of disease that passes from an animal to a human. The source stated that there are a reported 500,000 cases of human brucellosis each year, globally. However, true incidence is estimated to be 5,000,000 to 12,500,000 cases each year, globally.

According to the same source, brucellosis is recognized as the world's most common laboratory-acquired infection.

Key features of the study:

  • This report provides an in-depth analysis of the global brucellosis vaccines market, market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global brucellosis vaccines market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Merck & Co., Inc., CZ Vaccines, Colorado Serum Company, Indian Immunologicals Ltd., Hester Biosciences Limited, Veterinary Technologies Corporation, Jordan Bio-industries Center, Laboratorios Tornel, Fivet Animal Health and VETAL Animal Health Products Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global brucellosis vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global brucellosis vaccines market

Detailed Segmentation:

  • Global Brucellosis Vaccines Market, By Type:
    • RB51 Vaccine
    • S19 Vaccine
    • B19 Vaccine
    • Others (45/20 vaccine, SR82 vaccine, etc.)
  • Global Brucellosis Vaccines Market, By Application:
    • Cattle
    • Sheep
    • Goat
    • Others (swine, horses, etc.)
  • Global Brucellosis Vaccines Market, By Region:
    • North America
      • By Country
      • U.S.
      • Canada
    • Latin America
      • By Country
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • By Country
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Country
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • By Country
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • By Country/Region
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
    • Competitive Snapshot
      • Merck & Co., Inc.*
      • Company Overview
      • Application Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
      • CZ Vaccines
      • Colorado Serum Company
      • Indian Immunologicals Ltd.
      • Hester Biosciences Limited
      • Veterinary Technologies Corporation
      • Jordan Bio-industries Center
      • Laboratorios Tornel
      • Fivet Animal Health
      • VETAL Animal Health Products Inc.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Type
    • Market Snippet, By Application
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Drivers
  • Restraints
  • Opportunity
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Product Launch
  • Regulatory Guidelines
  • Acquisitions, Collaborations, & Partnerships
  • Epidemiology
  • PEST Analysis

4. Global Brucellosis Vaccines Market - Impact of Coronavirus (Covid-19) Pandemic

  • Economic Impact
  • Supply and Demand Analysis

5. Global Brucellosis Vaccines Market, By Type, 2017 - 2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • RB51 Vaccine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
  • S19 Vaccine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
  • B19 Vaccine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
  • Others (45/20 vaccine, SR82 vaccine, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)

6. Global Brucellosis Vaccines Market, By Application, 2017 - 2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Cattle
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
  • Sheep
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
  • Goat
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
  • Others (swine, horses, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)

7. Global Brucellosis Vaccines Market, By Region, 2017 - 2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, For Regions, 2018-2030
  • North America
    • Market Size and Forecast, By Type, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2030, (US$ Mn)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Type, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2030, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Type, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2030, (US$ Mn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Type, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2030, (US$ Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By Type, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2030, (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Type, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, By Region/Country, 2017 - 2030, (US$ Mn)
    • South Africa
    • Central Africa
    • North Africa

8. Competitive Landscape

  • Competitive Snapshot
    • Merck & Co., Inc.*
    • Company Overview
    • Application Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • CZ Vaccines
    • Company Overview
    • Application Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Colorado Serum Company
    • Company Overview
    • Application Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Indian Immunologicals Ltd.
    • Company Overview
    • Application Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Hester Biosciences Limited
    • Company Overview
    • Application Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Veterinary Technologies Corporation
    • Company Overview
    • Application Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Jordan Bio-industries Center
    • Company Overview
    • Application Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Laboratorios Tornel
    • Company Overview
    • Application Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Fivet Animal Health
    • Company Overview
    • Application Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • VETAL Animal Health Products Inc.
    • Company Overview
    • Application Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies

9. Section

  • References
  • Research Methodology
  • About us and Sales Contact